HVC
VKTX icon

Healthcare Value Capital’s Viking Therapeutics VKTX Stock Holding History

Healthcare Value Capital’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100,000
Closed -$721K – 21
2020
Q2 		$721K Hold
100,000
– – 1.84% 17
2020
Q1 		$468K Buy
+100,000
New +$615K 0.79% 25
2019
Q2 		– Sell
-100,000
Closed -$994K – 20
2019
Q1 		$994K Hold
100,000
– – 3.83% 8
2018
Q4 		$765K Buy
+100,000
New +$1.2M 2.97% 7

Other funds holding VKTX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Healthcare Value Capital's VKTX Position: Q1 2020 in Review

Healthcare Value Capital sold out of Viking Therapeutics (VKTX) in Q1 2020, closing a stake of 250,000 shares — an estimated $1.54M sold.

Healthcare Value Capital first reported a position in VKTX in Q2 2018 and held it in 7 quarters. The position peaked at $2.61M in Q3 2018. 137 funds tracked by Wall St. Rank hold VKTX as of Q1 2020.

  • Healthcare Value Capital reported no remaining Viking Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Healthcare Value Capital sold 250,000 Viking Therapeutics shares in Q1 2020, an estimated $1.54M.
  • Healthcare Value Capital first reported a position in Viking Therapeutics in Q2 2018 and held it in 7 quarters.
  • Healthcare Value Capital's Viking Therapeutics position peaked at $2.61M in Q3 2018.
  • 137 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2020.

Based on Healthcare Value Capital's 13F filing for Q1 2020, filed 15 May 2020.